FI119720B - Pitkävaikutteisten rakeisten valmisteiden valmistusmenetelmä - Google Patents
Pitkävaikutteisten rakeisten valmisteiden valmistusmenetelmä Download PDFInfo
- Publication number
- FI119720B FI119720B FI972622A FI972622A FI119720B FI 119720 B FI119720 B FI 119720B FI 972622 A FI972622 A FI 972622A FI 972622 A FI972622 A FI 972622A FI 119720 B FI119720 B FI 119720B
- Authority
- FI
- Finland
- Prior art keywords
- polymer
- temperature
- förfarande
- plasticizer
- granules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31441494 | 1994-12-19 | ||
JP31441494 | 1994-12-19 | ||
PCT/JP1995/002594 WO1996019200A1 (fr) | 1994-12-19 | 1995-12-18 | Preparation granulaire a liberation prolongee et procede de production |
JP9502594 | 1995-12-18 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI972622A0 FI972622A0 (fi) | 1997-06-18 |
FI972622A FI972622A (fi) | 1997-06-18 |
FI119720B true FI119720B (fi) | 2009-02-27 |
Family
ID=18053063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI972622A FI119720B (fi) | 1994-12-19 | 1997-06-18 | Pitkävaikutteisten rakeisten valmisteiden valmistusmenetelmä |
Country Status (14)
Country | Link |
---|---|
US (2) | US5858411A (no) |
EP (1) | EP0797987B1 (no) |
JP (1) | JP3893439B2 (no) |
KR (1) | KR100424931B1 (no) |
CN (1) | CN1093758C (no) |
AT (1) | ATE251896T1 (no) |
DE (1) | DE69531957T2 (no) |
DK (1) | DK0797987T3 (no) |
ES (1) | ES2210321T3 (no) |
FI (1) | FI119720B (no) |
NO (1) | NO320356B1 (no) |
PT (1) | PT797987E (no) |
TW (1) | TW406022B (no) |
WO (1) | WO1996019200A1 (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
ES2287971T3 (es) | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
US6632455B2 (en) * | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
DE19820801A1 (de) * | 1998-05-09 | 1999-11-25 | Gruenenthal Gmbh | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
EP1124541B1 (de) | 1998-09-30 | 2003-11-26 | Basf Aktiengesellschaft | Verwendung von wasserlöslichen oder wasserdispergierbaren polyether-haltigen pfropfpolymerisaten als überzugsmittel, bindemittel und/oder filmbildender hilfsstoff in pharmazeutischen darreichungsformen |
DE60039377D1 (de) * | 1999-02-09 | 2008-08-21 | Pfizer Prod Inc | Zusammensetzungen basischer Arzneistoffe mit verbesserter Bioverfügbarkeit |
US6316462B1 (en) * | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
GB0003782D0 (en) * | 2000-02-17 | 2000-04-05 | Dumex Ltd As | Process |
JP4310605B2 (ja) * | 2001-05-25 | 2009-08-12 | 大塚製薬株式会社 | 医薬用組成物 |
US20090214644A1 (en) * | 2003-07-31 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
US20050025825A1 (en) * | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050245614A1 (en) * | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
US20090215898A1 (en) | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
WO2006023000A1 (en) * | 2004-07-30 | 2006-03-02 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20060275365A1 (en) * | 2005-06-07 | 2006-12-07 | Thomas Backensfeld | Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof |
US20070059359A1 (en) * | 2005-06-07 | 2007-03-15 | Thomas Backensfeld | Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof |
WO2006133349A2 (en) * | 2005-06-08 | 2006-12-14 | Alpharma, Inc. | Orally disintegrable sleep aid formulations |
EP1919859B1 (en) | 2005-06-20 | 2010-06-02 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of tranexamic acid and use |
US20070036859A1 (en) * | 2005-08-11 | 2007-02-15 | Perry Ronald L | Sustained release antihistamine and decongestant composition |
RS53624B1 (en) * | 2006-03-16 | 2015-04-30 | Euro-Celtique S.A. | PHARMACEUTICAL SFEROIDS |
WO2009112874A1 (en) * | 2008-03-10 | 2009-09-17 | Eurodrug Laboratories B.V. | Modified release composition comprising doxofylline |
US20100280117A1 (en) * | 2009-04-30 | 2010-11-04 | Xanodyne Pharmaceuticals, Inc. | Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders |
WO2011091164A1 (en) * | 2010-01-22 | 2011-07-28 | Xenoport, Inc. | Oral dosage forms having a high loading of a tranexamic acid prodrug |
EP2540317A4 (en) * | 2010-02-22 | 2014-04-16 | Daiichi Sankyo Co Ltd | SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION |
GB201010083D0 (en) * | 2010-06-16 | 2010-07-21 | Univ Bradford | Compositions and methods |
KR102286952B1 (ko) * | 2013-12-31 | 2021-08-09 | 롯데정밀화학 주식회사 | 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말 |
WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
WO2018005552A1 (en) | 2016-06-27 | 2018-01-04 | Achillion Pharmaceuticals, Inc. | Quinazoline and indole compounds to treat medical disorders |
KR102632860B1 (ko) | 2017-03-01 | 2024-02-02 | 아칠리온 파르마세우티칼스 인코포레이티드 | 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물 |
US20230022157A1 (en) | 2018-08-20 | 2023-01-26 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
WO2020081723A1 (en) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
US4329451A (en) * | 1980-11-03 | 1982-05-11 | The Dow Chemical Company | Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative |
JPS57171428A (en) * | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
LU86099A1 (fr) * | 1985-09-30 | 1987-04-02 | Pharlyse | Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant |
CA1334379C (en) * | 1987-11-24 | 1995-02-14 | James William Mcginity | Method for preparing a solid sustained release form of a functionally active composition |
US5051261A (en) * | 1987-11-24 | 1991-09-24 | Fmc Corporation | Method for preparing a solid sustained release form of a functionally active composition |
US4835188A (en) * | 1987-12-08 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
US5326572A (en) * | 1989-03-23 | 1994-07-05 | Fmc Corporation | Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions |
EP0421582A1 (en) * | 1989-10-03 | 1991-04-10 | Warner-Lambert Company | Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and method for preparing same |
JPH03232814A (ja) * | 1990-02-08 | 1991-10-16 | Shin Etsu Chem Co Ltd | 徐放性錠剤の製造方法 |
JP2915590B2 (ja) * | 1991-02-15 | 1999-07-05 | 第一製薬株式会社 | マスクされた粒状物 |
AU1537292A (en) * | 1991-04-16 | 1992-11-17 | Nippon Shinyaku Co. Ltd. | Method of manufacturing solid dispersion |
DE4244466C2 (de) * | 1992-12-24 | 1995-02-23 | Pharmatech Gmbh | Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten |
-
1995
- 1995-12-18 EP EP95940461A patent/EP0797987B1/en not_active Expired - Lifetime
- 1995-12-18 CN CN95196885A patent/CN1093758C/zh not_active Expired - Fee Related
- 1995-12-18 JP JP51966196A patent/JP3893439B2/ja not_active Expired - Fee Related
- 1995-12-18 DK DK95940461T patent/DK0797987T3/da active
- 1995-12-18 DE DE69531957T patent/DE69531957T2/de not_active Expired - Lifetime
- 1995-12-18 PT PT95940461T patent/PT797987E/pt unknown
- 1995-12-18 AT AT95940461T patent/ATE251896T1/de not_active IP Right Cessation
- 1995-12-18 WO PCT/JP1995/002594 patent/WO1996019200A1/ja active IP Right Grant
- 1995-12-18 TW TW084113515A patent/TW406022B/zh not_active IP Right Cessation
- 1995-12-18 ES ES95940461T patent/ES2210321T3/es not_active Expired - Lifetime
- 1995-12-18 KR KR1019970703851A patent/KR100424931B1/ko not_active IP Right Cessation
- 1995-12-18 US US08/849,457 patent/US5858411A/en not_active Expired - Lifetime
-
1997
- 1997-06-18 FI FI972622A patent/FI119720B/fi active IP Right Grant
- 1997-06-18 NO NO19972814A patent/NO320356B1/no not_active IP Right Cessation
-
1998
- 1998-06-11 US US09/095,661 patent/US6030644A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5858411A (en) | 1999-01-12 |
NO320356B1 (no) | 2005-11-28 |
JP3893439B2 (ja) | 2007-03-14 |
NO972814D0 (no) | 1997-06-18 |
DE69531957D1 (de) | 2003-11-20 |
FI972622A0 (fi) | 1997-06-18 |
TW406022B (en) | 2000-09-21 |
DK0797987T3 (da) | 2004-02-16 |
ES2210321T3 (es) | 2004-07-01 |
EP0797987A1 (en) | 1997-10-01 |
DE69531957T2 (de) | 2004-08-12 |
EP0797987B1 (en) | 2003-10-15 |
FI972622A (fi) | 1997-06-18 |
CN1093758C (zh) | 2002-11-06 |
KR100424931B1 (ko) | 2004-07-05 |
CN1170357A (zh) | 1998-01-14 |
ATE251896T1 (de) | 2003-11-15 |
US6030644A (en) | 2000-02-29 |
EP0797987A4 (en) | 1998-09-09 |
WO1996019200A1 (fr) | 1996-06-27 |
PT797987E (pt) | 2004-02-27 |
NO972814L (no) | 1997-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI119720B (fi) | Pitkävaikutteisten rakeisten valmisteiden valmistusmenetelmä | |
EP2961387B1 (en) | Delayed release film coatings containing calcium silicate and substrates coated therewith | |
CA2556514C (en) | Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same | |
KR20050034620A (ko) | 약물용 피복제 또는 결합제를 제조하기 위한 과립 또는 분말 | |
JP2007501256A (ja) | 水溶性薬物を含有する医薬組成物 | |
AU2004251541B2 (en) | Sustained drug-release particles and process for producing the same | |
TW201204415A (en) | Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same | |
EP3687502B1 (en) | Solid simethicone particles and dosage form thereof | |
Amelian et al. | Polymers in pharmaceutical taste masking applications | |
JP4779970B2 (ja) | 経口製剤およびその製造方法 | |
KR100913281B1 (ko) | 서방 제제 및 그의 제조 방법 | |
TW200829287A (en) | Short term slow release drug delivery system | |
JP5297194B2 (ja) | 初期溶解率が改善されたプランルカスト固体分散体の薬剤学的組成物およびその製造方法 | |
JP6027550B2 (ja) | 医薬剤形用の安定した保護被覆のための粉末被覆剤の製造 | |
JPH0691150A (ja) | マスクされた粒状物 | |
EP2201939A1 (en) | Method for producing coated spiramycin and novel formulations containing the same | |
PL193028B1 (pl) | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu chlorku potasu oparte na granulkach o wysokiej zawartości składnika aktywnego oraz sposób ich wytwarzania | |
JP2012087073A (ja) | コーティング粒子の製造方法、及び該製造方法で製造されたコーティング粒子 | |
KR20120084296A (ko) | 불쾌미 마스킹 입자 및 이것을 함유하는 경구제제 | |
TW201240660A (en) | Pharmaceutical composition for treating HCV infections | |
US10772826B2 (en) | Controlled release of active substances | |
CA2207334C (en) | Sustained-release granular preparations and production process thereof | |
XIAOHUA | Controlled release alginate-based microparticulate systems for drug delivery and chemoembolization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 119720 Country of ref document: FI |